Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 01 - 19 tags : Fda save search
Histogen Reports FDA Clinical Hold for Planned Phase 1/2 Trial of HST-003 for Knee Cartilage Regeneration
Published: 2021-01-19 (Crawled : 22:00) - biospace.com/
HSTO 4 d | $0.35 67.46% 5.4K
|
Health Technology
|
| O: 5.49%
H: 9.67%
C: 9.67%
fda cartilage trial phase 3 phase 1 phase 2 clinical hold
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT7455, an Orally Bioavailable MonoDAC for Hematologic Malignancies– Phase 1/2 Clinical Study of CFT7455 Expected to Initiate in 1H 2021 –
Published: 2021-01-19 (Crawled : 20:00) - biospace.com/
CCCC | $6.47 -6.23% -6.65% 1M
|
Health Technology
|
| O: 3.13%
H: 3.94%
C: 0.05%
fda clearance fda drug new drug phase 3 phase 1 phase 2 clearance
Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: 7.62%
H: 2.9%
C: 0.12%
fda license application
DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.06%
H: 0.64%
C: 0.48%
fda clearance fda clearance designation
Molecular Templates Announces FDA Acceptance of IND Application for MT-6402, a PD-L1-Targeted Engineered Toxin Body Enabled with Proprietary Antigen Seeding Technology
Published: 2021-01-19 (Crawled : 13:05) - globenewswire.com
MTEM | $1.55 3.54% 15K
|
Health Technology
|
| O: 2.08%
H: 6.83%
C: 4.52%
molecular fda fda acceptance rpd
Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
Published: 2021-01-19 (Crawled : 12:03) - globenewswire.com
DTIL | $9.81 -4.11% -4.28% 34K
|
Health Technology
|
| O: 9.91%
H: 18.6%
C: 17.87%
fda fda acceptance car-t
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT7455, an Orally Bioavailable MonoDAC for Hematologic Malignancies
Published: 2021-01-19 (Crawled : 12:03) - globenewswire.com
CCCC | $6.47 -6.23% -6.65% 1M
|
Health Technology
|
| O: 3.13%
H: 3.94%
C: 0.05%
fda clearance fda drug new drug application clearance
Metacrine Announces FDA Fast Track Designation for MET642 as a Treatment of NASH
Published: 2021-01-19 (Crawled : 12:00) - globenewswire.com
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 7.78%
H: 1.44%
C: -1.96%
fda treatment fast track met642 nash fda fast track fast track designation designation
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.